Compare VCEL & BPOPM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VCEL | BPOPM |
|---|---|---|
| Founded | 1989 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | N/A |
| IPO Year | 1997 | N/A |
| Metric | VCEL | BPOPM |
|---|---|---|
| Price | $37.36 | $25.45 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $57.50 | N/A |
| AVG Volume (30 Days) | ★ 586.8K | N/A |
| Earning Date | 02-26-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 236.54 | N/A |
| EPS | ★ 0.25 | N/A |
| Revenue | ★ $258,716,999.00 | N/A |
| Revenue This Year | $17.86 | N/A |
| Revenue Next Year | $18.55 | N/A |
| P/E Ratio | $151.65 | ★ N/A |
| Revenue Growth | ★ 14.05 | N/A |
| 52 Week Low | $29.24 | N/A |
| 52 Week High | $63.00 | N/A |
| Indicator | VCEL | BPOPM |
|---|---|---|
| Relative Strength Index (RSI) | 48.73 | 53.07 |
| Support Level | $35.99 | $25.43 |
| Resistance Level | $41.65 | $25.65 |
| Average True Range (ATR) | 1.75 | 0.13 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 32.12 | 66.67 |
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
Popular Capital Trust II is a statutory trust. It is engaged in issuing capital securities.